|
POLICY & REGULATION
LITIGATION
Trade Group Latest To Sue Wash. Over 340B Drug Pricing Law
By Rachel Riley
Pharmaceutical Research and Manufacturers of America claims a new Washington state law attempts to illegally reshape the federal 340B Drug Pricing Program and singles out participating drugmakers with burdensome regulations, according to a fresh federal lawsuit that follows similar constitutional challenges mounted by Novartis and AbbVie.
2 documents attached |
Read full article »
| Save to favorites »
Ga. Providers Say Rutledge Bars United's Preemption Win
By Kelcey Caulder
Medical providers are urging a Georgia federal court to deny United's bid for an early win in its case seeking a declaration that the providers' purported attempt to claw back reimbursements for out-of-network services are preempted, arguing that state-law claims involving employee benefits aren't preempted by federal benefits law.
Brief attached |
Read full article »
| Save to favorites »
DEALS
BANKRUPTCY
EXPERT ANALYSIS
Keys To Building Defensible Psychedelic Therapy Programs
Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|